Zoetis, Inc. (ZTS) | Stock price, performance, AI analysis | Thematic | AI powered fundamental research and development platform

Loading...

Research a topic Stock screener Find companies

Search for securities Load an existing portfolio Backtest

How to use About us Blog

|

Research a topic Stock screener Find companies

Search for securities Load an existing portfolio Backtest

How to use About us Blog

Follow our journey and product updates

Product

Research a topic Stock screener Find companies Search for securities Load an existing portfolio Backtest

Learn

Thematic overview Develop asset-backed products Company evaluations Backtesting and benchmarking Thematic branded indices Build investment strategies with crypto

Company

How to use About us Blog

Team Research

There is currently no saved research for this page.

Zoetis, Inc. (ZTS)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation

Company performance

Add to research

Current Price

as of May 12, 2025

$161.92

P/E Ratio

29.08

Market Cap

$72.09B

Description

Add to research

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Metrics

Add to research

Overview

HQParsippany, NJ
SectorHealth Technology
IndustryPharmaceuticals: Major
TickerZTS
Price$161.92+1.66%

Trading Information

Market cap$72.09B
Float99.90%
Average Daily Volume (1m)3,160,899
Average Daily Volume (3m)3,072,638
EPS$5.58

Company

Revenue$9.29B
Rev growth (1yr)1.37%
Net income$631.00M
Gross margin70.54%
EBITDA margin43.47%
EBITDA$965.00M

EV$78.79B
EV/Revenue8.49
P/E29.08
P/S7.81
P/B15.52
Debt/Equity145.01

Documents

Add to research

SEC Filings

8-K (2025-05-06)

8-K (2025-02-13)

8-K (2025-02-06)

8-K (2025-01-13)

8-K (2024-12-12)

8-K (2024-11-12)

8-K (2024-11-04)

8-K (2024-10-10)

8-K (2024-08-06)

8-K (2024-08-01)

8-K (2024-05-24)

8-K (2024-05-23)

8-K (2024-05-22)

8-K (2024-05-02)

8-K (2024-04-16)

8-K (2024-04-01)

8-K (2024-02-13)

8-K (2024-02-06)

8-K (2023-12-07)

8-K (2023-11-02)

8-K (2023-10-12)

8-K (2023-08-08)

8-K (2023-05-25)

8-K (2023-05-19)

8-K (2023-05-11)

8-K (2023-05-04)

8-K (2023-02-14)

8-K (2023-02-08)

8-K (2023-02-07)

10-Q (2025-05-06)

10-Q (2024-11-04)

10-Q (2024-08-06)

10-Q (2024-05-02)

10-Q (2023-11-02)

10-Q (2023-08-08)

10-Q (2023-05-04)

10-K (2025-02-13)

10-K (2024-02-13)

10-K (2023-02-14)

Earnings Calls

Earnings Report 2025Q1

Earnings Report 2024Q4

Earnings Report 2024Q3

Earnings Report 2024Q2

Earnings Report 2024Q1

Earnings Report (2023-11-02)

Earnings Report (2023-08-08)

Factset

Factset Business Description

Factset Street Account

Zoetis reports Q3 EPS $1.36 ex-items vs FactSet $1.36 [11 est, $1.32-1.41] ($151.44, 0.00) (2023-11-02T11:04:49Z)

StreetAccount Metrics Recap - Zoetis Q3 Earnings ($151.44, 0.00) (2023-11-02T11:07:30Z)

StreetAccount Earnings Call Q&A Summary: Zoetis Q3 ($ 158.93, +7.49) (2023-11-02T13:56:29Z)

StreetAccount Consensus Metrics Preview - Zoetis Q3 Earnings ($156.31, +0.28) (2023-10-30T16:59:05Z)

Wikipedia

Ask a question

New feature

Thematic Research

View all of your research in one place. Toggle open the floating actions menu and click Open research sidebar to view your saved research for the current page.